Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-I

Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647

Quick Stats
Studies 225
Trials 100
Score 1
2004 pubmed

The role of melanocortin-3 and -4 receptor in regulating appetite, energy homeostasis and neuroendocrine function in the pig.

Barb. C R CR; Robertson. A S AS; Barrett. J B JB; Kraeling. R R RR; Houseknecht. K L KL

Key Findings

  • Intracerebroventricular NDP‑MSH (an MC3/4 agonist) lowered feed intake in growing pigs for up to 72 hours.
  • The MC3/4 antagonist SHU9119 did not increase feed intake, suggesting other brain factors may block its effect.
  • Pigs carried a heterozygous MC4‑R missense mutation, which may alter receptor function and explain the weak feeding response.

Practical Outcomes

  • For biohackers, this work offers little direct guidance. It shows that MC3/4 receptor activation can curb appetite in pigs, but the same approach may not translate to humans, especially given species‑specific receptor mutations. No clear dosing or protocol for melanotan‑I or related peptides emerges from this study.

Summary

In pigs, activating brain receptors MC3/4 with a drug called NDP‑MSH reduced how much they ate, but blocking those receptors didn’t make them eat more. The study also found that a common MC4‑R mutation in pigs might change how these receptors work, and the drugs didn’t affect growth‑hormone or luteinising‑hormone levels.

Abstract

A recently discovered class of receptors, melanocortin-3 and -4 receptor (MC3/4-R), are located within the brain and modulate feed intake in rodents. Stimulation of the receptor (agonist) inhibits feed intake whereas blockade (antagonist) of the receptor increases intake. Our knowledge of factors regulating voluntary feed intake in humans and domestic animals is very limited. i.c.v. administration of an MC3/4-R agonist, NDP-MSH, suppressed (P<0.05) feed intake compared with controls at 12, 24, 48 and 72 h after treatment in growing pigs. Fed pigs were more responsive to the MC3/4-R agonist then fasted animals. However, i.c.v. treatment with MC3/4-R antagonist, SHU9119, failed to stimulate intake. The failure of MC3/4-R antagonist to stimulate feed intake suggests involvement of other brain hormone(s) which antagonize the action of SHU9119 at the MC3/4-R, blocking its stimulatory effect on intake. Treatment with NDP-MSH or SHU9119, across a wide dose range, failed to affect LH and GH secretion, except for the 10 micro g dose of NDP-MSH, which exhibited both a stimulatory and an inhibitory effect on GH secretion in fasted animals. Treatment with agouti-related peptide, a natural brain hormone that blocks the MC3/4R, failed to stimulate feed intake. These results do not support the idea that endogenous melanocortin pays a critical role in regulating feed intake and pituitary hormone secretion in the pig. SHU9119 blocked the NDP-MSH-induced increase in cAMP in HEK293 cells expressing the porcine MC4-R sequence without the missense mutation. The EC(50) and IC(50) values were similar to the human MC4-R, confirming that SHU9119 is a pig MC4-R antagonist. However, pigs were heterozygous for an MC4-R gene missense mutation. It is possible that the MC4-R mutation alters function and this may explain the failure to demonstrate MC3/4-R involvement in modulating feeding behavior and LH and GH secretion in the pig.

Study Information

Provider

pubmed

Year

2004

DOI

10.1677/joe.0.1810039